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Abstract
Background: Although the gastric well-differentiated adenocarcinoma in the distal stomach has been thought to
develop via a intestinal metaplasia-carcinoma sequence, there are some disproofs from new mucin examinations for
minute-size lesions in same type carcinoma. The current study was performed and pointed out the new findings for the
solution to the problem according to the point described above.
Methods: 12 super-minute lesions (less than 1 mm in maximum diameter) of well-differentiated adenocarcinoma in
distal stomach (SMCa), which were detected from the pathological examinations of 210 surgically resected stomach
specimens, and the mucosa adjacent to these carcinoma lesions, were examined by immunohistochemical mucin stainings
(MUC2 and CD-10: intestinal phenotype, 45M1 and MUC6: gastric phenotype) and p53-overexpression. And the
analyses of the replication error of the microsatellites in chromosome 17 related p53 gene (TP53 and D17S786) (RER-
p53MS) were performed in SMCa lesions, adjacent mucosa to each lesion and other gastric mucosa with intestinal
metaplasia, because all SMCa lesions showed p53-overexpression immunohistochemically, decribed below.
Results: 1. The carcinoma cells in all SMCa lesions were positive for 45M1 and p53. On the other hand, no positive
carcinoma cells for MUC6 were seen although the pyloric glands and the remnant pyloric gland in the SMCa lesions in
the same slides were positive for MUC6. Ten lesions (83%) had intestinal phenotypic mucin (10 lesions: MUC2 (+), 4
lesions: CD10 (+)). Two lesions (17%) were positive for only 45M1 (gastric phenotypic mucin). 2. All of the mucosa
adjacent to SMCa showed intestinal metaplasia (complete type: 7 regions, incomplete type: 5 regions). 3. RER-p53MS was
confirmed in 42% (5/12 regions) of SMCa, in 42% (5/12 regions) of the mucosa adjacent to SMCa and 14% (6/42 regions)
of the other intestinal metaplasia mucosa.
Conclusion: Most of the super-minute well-differentiated adenocarcinoma lesions in the distal stomach, which had both
gastric and intestinal phenotypic mucin, are considered to develop from the tubular proliferative zone with the
incomplete type of the intestinal metaplasia and p53 gene abnormality, while a part of them, which had only gastric
phenotypic mucin, may derive from the gastric native tubules (non-metaplastic epithelium) with p53 gene abnormality.
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Background
Although the gastric differentiated adenocarcinoma has
been thought to develop via a intestinal metaplasia-carci-
noma sequence [1-4], there are some disproofs [5] that
the gastric differentiated adenocarcinoma develops hav-
ing a poor relationship to the intestinal metaplasia, from
new mucin examinations for minute-size carcinoma [6,7]
in same type. Thus, some problems for that histogenesis
of the gastric differentiated adenocarcinomaare consid-
ered to be still remained.
To clarify the true histogenesis of digestive tract carci-
noma, the extremely small-sized carcinoma lesions were
found and these lesions including the mucosa adjacent to
them must be examined pathologically and molecular-
biologically. Because almost all lesions of the digestive
tract carcinoma develop from the mucosal epithelium and
the minute-sized carcinoma lesions and the mucosa adja-
cent to them may express the initial condition when each
carcinoma develop.
According to the point described above, the current study
was performed and pointed out the new findings for the
solution to this problem.
In this study, firstly, the immunohistochemical mucin-
stainings and p53-overexpression, and secondary, the rep-
lication error (RER) of the microsatellite (MS) in chromo-
some 17 related p53 gene of the super-minute sized
differentiated adenocarcinoma lesions in the human
stomachs, whose definition was described below, were
investigated, because the carcinoma cells were positive
p53 in all carcinoma lesions in the current study, and the
new findings on histogenesis of gastric adenocarcinoma
were revealed.
Methods
Twelve tubular proliferative lesions (within 1 mm in max-
imum diameter) with cellular atypia and the boundaries
to the neighborhood, which were diagnosed as high-grade
intraepithelial neoplasia according to both the Vienna
and WHO classification [8,9] and as well-differentiated
adenocarcinoma according to the classification of the Jap-
anese Research Society for Gastric Cancer [10] (the super
minute-sized well-differentiated adenocarcinoma in the
distal stomach: SMCa) (Figure 1 &2), were detected in the
distal stomachs from the pathological examinations of
210 surgically resected stomach specimens with early can-
cer, assessed at the Department of Pathology, Juntendo
University hospital and Shizuoka Hospital, between 1982
and 2003. Although in the cases between 1999 and 2003
the informed consent for pathological and molecular
examinations were obtainted from each patient, in other
cases the informed consent could not be obtained because
the system of the informed consent for patients was built
up at 1999.
The stomach specimens described above were fixed in
10% buffered formalin solution and prepared by cutting
from almost the entirety of the stomachs area into 3 – 5
mm wide sections. Each section was embedded in paraffin
and stained with hematoxylin and eosin (HE). And every
sections with 12 SMCa lesions described above were cut
serially and stained with HE, and the greatest dimensions
of these lesions were determined (655 – 958 µm). The
cases with SMCa lesions were considered as the cases of
multiple gastric cancers by the criteria of Moertel et al.
[11].
Typical case of SMCa Figure 1
Typical case of SMCa. SMCa lesion is seen in the center 
region of this fugure. (×20, HE)
High power view of Figure 1 lesion Figure 2
High power view of Figure 1 lesion. This lesion was diag-
nosed as high-grade intraepithelial neoplasia according to 
both the Vienna and WHO classification and as well-differen-
tiated adenocarcinoma according to the classification of the 
Japanese Research Society for Gastric Cancer. (×200, HE)Journal of Carcinogenesis 2005, 4:14 http://www.carcinogenesis.com/content/4/1/14
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Using all paraffin blocks with SMCa lesions and 10 paraf-
fin blocks with no neoplasia in each stomach, and the
mucosa adjacent to SMCa lesions were examined by
immunohistochemical mucin stainings as shown in Table
1 (MUC2 and CD-10: intestinal phenotype, 45M1 and
MUC6: gastric phenotype). These 4 mucin stainings are
more popular for detection the mucin phenotypes of the
gastric differentiated adenocarcinoma [12].
And we have tried to examine a number of Exons for
detecting the p53 gene abnormalities, because all lesions
of the gastric super-minute well-differentiated adenocarci-
nomas showed overexpression of p53 immunohisto-
chemically, described below (in "Results"). However, it
was hard to examine it, because the target fici were too
small and in post-formalin solution condition. Second-
ary, we have tried to estimate the existence or nonexist-
ence of the p53 gene abnormalities using microsatellite
markers in chromosome 17 related p53 gene (RER-
p53MS).
Immunohistochemical stainings
Immunohistochemical mucin-stainings were performed
by the avidin-biotin-peroxidase-complex method with
each condition as shown in Table 1. Recently, it has been
pointed out that the data of the mucin phenotypes of the
lesions will change accroding to what percentage of posi-
tive cells in each stainings is judged as the positive in each
stainings [13]. In this study, the mucin phenotypes of the
lesions were determined by positive (>0% of the carci-
noma cells) or negative. Because the target lesions in this
study were extremely small lesions, and even if only a car-
cinoma cell was positive, this positivity should be consid-
ered to be the effective and valuable data. And p53-
oncoprotein antibody staining with microwave treatment
was done in many sections (p53: DO-7, Novocastra Inc.,
UK).
DNA extraction and analysis of RER-p53MS using 
microsatellite markers (TP53 and D17S786)
Paraffin blocks with the target foci mentioned above were
prepared for DNA extraction. The target foci were micro-
dissected using a 20-gauge needle, comparing the slide
with HE staining in the same position. The extracted DNA
was diluted with 500 µl DNA Isolation Solution (DNA
isolater for DNA Extraction from Paraffin-embedded Tis-
sue, Wako Inc., Osaka). In this study, target foci were
SMCa and other gastric non-neoplastic mucosa and the
extracted DNA from them were used as template DNA in
polymerase chain reaction (PCR). However, in approxi-
mately half of target foci, DNA could not be extracted,
because these target foci may be too small and moreover
these materials were done by the formalin-solution. And
decribed above, as the purpose of the molecular
Table 1: Immunohistochemical mucin antibodies
Commercial name Positive cell Dilution Source
MUC2 Human Muc2 glycoprotein Goblet cell and their precursor cell 1:500 Novocastra, UK
CD10 CD10 glycoprotein Enterocytes 1:200 Novocastra, UK
45M1 Peptide core of human gastric mucin 
(NCL-HGM-45M1)
Gastric surface mucous cell 1:100 Novocastra, UK
MUC6 Human Muc6 glycoprotein Pyloric gland, mucous neck cell, 
cardiac gland, Brunner's gland
1:100 Novocastra, UK
The shift (+) was determined when a new peak not recog- nized with non-neoplastic and metaplastic tissue (lower view  in Figure 3) was confirmed with the target mucosa with intes- tinal metaplasia or SMCa lesions (upper view in Figure 3),  that is to say, RER-p53MS was positive Figure 3
The shift (+) was determined when a new peak not recog-
nized with non-neoplastic and metaplastic tissue (lower view 
in Figure 3) was confirmed with the target mucosa with intes-
tinal metaplasia or SMCa lesions (upper view in Figure 3), 
that is to say, RER-p53MS was positive.Journal of Carcinogenesis 2005, 4:14 http://www.carcinogenesis.com/content/4/1/14
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biological examinations was to know the existence or
nonexistence of p53 gene abnormalities of target foci,
TP53 and D17S786 were selected as microsatellite mark-
ers in the current study, according the proposition by
National Cancer Institute Workshop [14].
RER-p53MS was investigated using high resolution fluo-
rescenced labeled PCR primers in proportion to the
method of Tsuchida et al. [15]. The outline of it: 1. PCR
was performed containing 1 µL of DNA lysate, 100 µM
dNTP, 1.5 mM MgCl2, 1 µM each primer marked with flu-
orescent dye of three colors as blue, green and yellow,
0.625 U Taq DNA polymerase and 1 × PCR buffer [con-
taining 10 mM Tris-HCl (pH 8.3 at 25°C), 50 mM KCl
and 0.001%(w/v) gelatin] in a thermal cycler. 2. The elec-
trophoresis was conducted 2 hours by means of an ABI-
377 DNA auto-sequencer (PE Bio-systems, Inc., Foster
City, CA, USA). 3. A comparison was made of peaks of
same marker arising from gastric non-neoplastic and
metaplastic mucosa and SMCa lesions, using the Gene
Scan TM waveform analyzed softwave, and shift were
assessed. The shift (+) was determined when a new peak
not recognized with non-neoplastic and metaplastic tis-
sue was confirmed with the target mucosa with intestinal
metaplasia or SMCa lesions, that is to say, RER-p53MS
was positive (Figure 3).
Although we have tried to examine the existence of Heli-
cobacter pylori in the SMCa lesions and the mucosa
adjacent to them, the surface mucous layer of specimen
stomachs, in which Helicobacter pylori may often exist,
was washed away at taking photograph of each specimen,
and the relationship between SMCa and Helicobacter
pylori could not be examined.
The data were analyzed statistically with Student's t-test (t-
test) and chi-square test; a p-value of less than 0.05 was
considered to be significant.
Results
1. Mucin phenotypes of SMCa (Table 2)
The carcinoma cells in all SMCa lesions were positive for
45M1 (Figure 4). On the other hand, no carcinoma cells
in all SMCa lesions were positive for MUC6, although the
pyloric glands and the remnant pyloric glands in SMCa
lesions, which were seen in the same slides, were positive
for MUC6. Ten lesions (83%) had intestinal phenotypic
mucin (10 lesions: MUC2 (+), 4 lesions: CD10 (+)) (Fig-
ure 5). Two lesions (17%) were positive for only 45M1.
That is to say, among SMCa lesions, 10 lesions (83%) had
both gastric and intestinal phenotypic mucin and 2
lesions (17%) had only gastric phenotypic mucin.
2. The mucosa adjacent to SMCa lesions
All of the mucosa adjacent to SMCa showed intestinal
metaplasia (complete type: 7 regions, incomplete type: 5
regions, by the criteria of Filipe et al. [16]).
3. p53-overexpression and frequency of RER-p53MS in 
SMCa and the mucosa adjacent to them
Although most of the carcinoma cells in every SMCa was
positive for p53 (Figure 6), there was no positive cell for
p53 in the mucosa adjacent to SMCa and other intestinal
metaplasia.
RER-p53MS was confirmed in 42% (5/12 regions) of
SMCa, in 42% (5/12) of the mucosa adjacent to SMCa
and 14% (6/42) of the other intestinal metaplasia mucosa
(complete type: 17%, 4/23, incomplete type: 11%, 2/19),
as shown in Table 3.
Discussion
Although gastric differentiated adenocarcinoma is
thought to develop from intestinal metaplasia [1-4], there
are the disproof reports using a new mucin examination
methods [5-7]. Thus, the histogenesis of the gastric differ-
entiated adenocarcinoma may be still unclear.
The small carcinoma lesion is thought to be a good model
for researching the histogenesis of digestive tract carci-
noma, because almost all lesions of the digestive tract car-
cinoma develop from the mucosal epithelium and the
minute-sized carcinoma lesions and the mucosa adjacent
to them may express the initial condition when each car-
cinoma develop. Therefore, the carcinoma lesions must
be as small as possible to examine the original findings in
the mucin phenotypes or the gene abnormalities, and
moreover the essential mucin expression in the small
Table 2: Mucin phenotypes of SMCa
Case MUC6 45M1 MUC2 CD10
1- + + +
2- + - -
3- + + -
4- + + +
5- + + -
6- + + -
7- + + -
8- + - -
9- + + +
10 - + + -
11 - + + -
12 - + + +
Total 0% (0/12) 100% (12/12) 83% (10/12) 34% (4/12)Journal of Carcinogenesis 2005, 4:14 http://www.carcinogenesis.com/content/4/1/14
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lesions must be determined as 'positive' even if a carci-
noma cell was positive.
Thus, the mucin expression and gene abnormalities in
super-minute-sized gastric well-differentiated adenocarci-
noma, which have been shown in the initial stages of
same type-carcinoma, are still thought to be unclear and
the current study was performed focussing on this, and
some interesting findings were revealed in the current
study.
SMCa in the current study was defined as the tubular pro-
liferation with cellular and structural atypia, diagnosed as
high-grade intraepithelial neoplasia according to the
Vienna [8] and WHO classification [9], and as well-differ-
entiated adenocarcinoma according to the classification
of the Japanese Research Society for Gastric Cancer [10].
Thus, SMCa lesions were thought to be the initial stage of
development of the gastric well-differentiated
adenocarcinoma.
Our results in the current study showed that 1. Among
SMCa lesions, all carcinoma lesions were positive for
45M1 and p53, and no carcinoma cells were positive for
MUC6. Ten SMCa lesions (83%) had intestinal pheno-
typic mucin (10 lesions: MUC2 (+), 4 lesions: CD10 (+)).
Two SMCa lesions (17%) were positive for only 45M1.
That is to say, among SMCa lesions, 10 lesions (83%) had
both gastric and intestinal phenotypic mucin and 2
lesions (17%) had only gastric phenotypic mucin. 2. All of
the mucosa adjacent to SMCa showed intestinal
metaplasia (complete type: 7 regions, incomplete type: 5
regions). 3. RER-p53MS was confirmed in 42% (5/12
Among SMCa lesions, all lesions were positive for 45M1 Figure 4
Among SMCa lesions, all lesions were positive for 45M1. 
(×200, 45M1 in Figure 1 lesion)
Ten lesions were positive for MUC2 Figure 5
Ten lesions were positive for MUC2. (×200, MUC2 in Figure 
1 lesion)Journal of Carcinogenesis 2005, 4:14 http://www.carcinogenesis.com/content/4/1/14
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regions) of SMCa, in 42% (5/12 regions) of the mucosa
adjacent to SMCa and 14% (6/42 regions) of the other
intestinal metaplasia mucosa.
Although the mucin phenotypes of SMCa lesions differed
from the data of other reports using the gastric minute dif-
ferentiated adenocarcinoma [6,7], the reason of the
differences may be caused the differences of the definition
of the positivity in each stainings decribed above. In the
current study, the lesions were judged as 'positive' even if
a carcinoma cell was positive in each staining. The data in
RER-p53MS of SMCa was almostly equal to the data of MS
instability or the loss of heterozygosity in the gastric dif-
ferentiated adenocarcinoma and intestinal metaplasia in
other reports [17-19].
Focusing on the histogenesis of the gastric diffrentiated
adenocarcinoma, the results of mucin expressions of
SMCa revealed that gastric well-differentiated adenocarci-
noma should not derive from the intestinal metaplasia
with no remnant gastric original tubules (the tubules
exchanged perfectly by intestinal metaplasia), because all
of SMCa lesions had the gastric phenotypic mucin. How-
ever, most of SMCa may develop having a relashionship
to the intestinal metaplasia, because they had also the
intestinal phenotypic mucin. Namely, most of the SMCa
lesions should derive from the gastric native tubule with a
part of intestinal metaplasia and p53 gene abnormality.
On the other hand, a minority of SMCa had only gastric
phenotypic mucin, are considered to develop from the
gastric native tubules with no intestinal metaplasia and
with p53 gene abnormality.
Thus, when the judgements of the mucin expressions in
the gastric super-minute well-differentiated
adenocarcinoma were strictly performed like as the cur-
rent study, although the main route of the histogenesis of
the gastric differentiated adenocarcinoma is thought to be
the intestinal metaplasia-carcinoma sequence as before, it
is very important that some well-differentiated adenocar-
cinoma may derive from the gastric native tubules with no
relationship to the intestinal metaplasia. That is say, the
intestinal metaplasia should not be the indispensable fac-
tor in the development of the well-ifferentiated adenocar-
cinoma in the distal stomach.
In the current study, the target lesions were limited to the
lesions in the distal stomach, because the carcinoma
lesions as like SMCa lesions could not be found in proxi-
mal stomach including the gastric cardia. Thus, we could
not point out the histogenesis of the gastric well-differen-
Anti-p53 antibody staining (p53) in Figure 1 lesion Figure 6
Anti-p53 antibody staining (p53) in Figure 1 lesion. Most of 
the carcinoma cells in this lesion showed a positive reaction 
for p53. (×200, p53)
Table 3: Frequency of RER-p53MS in SMCa, the mucosa adjacent to them and intestinal metaplasia
TP53 D17S786
SMCa 42% (5/12 resions) 8% (1/12 regions)
Mucosa adjacent to SMCa (intestinal 
metaplasia)
42% (5/12 regions) 17% (2/12 regions)
Other intestinal metaplasia 14% (6/42 regions) 5% (2/42 regions)Publish with BioMed Central    and   every 
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tiated adenocarcinoma in the whole stomach. The further
study between the histogenesis of gastric differentiated
adenocarcinoma and the intestinal metaplasia is
expected.
Abbreviations
SMCa, super-minute lesions (less than 1 mm in maxi-
mum diameter) of well-differentiated adenocarcinoma in
distal stomach; RER, replication error; MS, microsatellite
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